Skip to content

Moderate Intensity Continuous Exercise

OTHER7 trials

Sponsors

University Health Network, Toronto, Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques, University of North Carolina, Chapel Hill, University of British Columbia, Riphah International University

Conditions

Acute ExerciseBreast Cancer Cell LinesBreast Cancer SurvivorsDiabetes Mellitus, Type 1Healthy WomenInflammationMyokine ResponseOverweight

Unknown Phase

High Intensity Interval Training for People With Stroke Deficits
NCT03006731
University Health Network, TorontoStroke
Start: 2017-03-01End: 2023-08-31Updated: 2023-05-09
Post Exercise Substrate Oxidation, Appetite and Energy Intakes in Overweight/Obese Postmenopausal Women (EScAPE)
CompletedNCT04364061
Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et PathologiquesOverweight, Postmenopausal
Start: 2019-11-01End: 2020-04-01Updated: 2020-04-28
Isoenergetic High Intensity Interval Training and Moderate Intensity Training in Adults With Type I Diabetes
CompletedNCT04664205
University of North Carolina, Chapel HillDiabetes Mellitus, Type 1
Start: 2021-02-01End: 2022-09-15Updated: 2024-07-26
Impact of Acute Exercise Intensity and Pattern on Cytokine Function
CompletedNCT05574413
University of British ColumbiaInflammation
Start: 2022-09-15End: 2023-09-01Updated: 2023-12-06
Effect of Low-Volume HIT vs. MIC Exercise in Individuals With Increased BMI
CompletedNCT06584708
Riphah International UniversityOverweight and Obesity
Start: 2024-02-15End: 2024-09-01Updated: 2024-11-22
Baroreflex Sensitivity Response to Exercise
CompletedNCT06709560
Egas Moniz - Cooperativa de Ensino Superior, CRLSex
Start: 2023-01-02End: 2023-07-28Updated: 2024-11-29
Tumour Cell Response to Acute Aerobic Exercise in Breast Cancer Survivors: Modulatory Effects of Exercise Type and Intensity
RecruitingNCT07439458
Riga Stradins UniversityAcute Exercise, Breast Cancer Cell Lines, Breast Cancer Survivors +2
Start: 2024-04-01End: 2026-03-31Target: 40Updated: 2026-02-27

Related Papers